Medicine and Dentistry
Adult
36%
Adverse Event
17%
Arm
10%
Bevacizumab
7%
Brain
33%
Brain Tumor
16%
Brainstem
16%
Cancer Therapy
7%
Chemoradiotherapy
10%
Combination Therapy
53%
Combined Therapy
7%
Consensus
8%
Follow up
6%
Gadolinium
8%
Glioblastoma
100%
Hippocampus
8%
Hypofractionated Radiotherapy
33%
Magnetic Resonance Imaging
8%
Malignant Neoplasm
12%
Neoplasm
17%
Neuro-Oncology
20%
Optic Nerve
8%
Organ
33%
Overall Survival
24%
Patient
86%
Phase I Trials
33%
Physician
10%
Pituitary Gland
8%
Progression Free Survival
10%
Radiation Therapy
30%
Recurrent Disease
37%
Skull
66%
Skull Defect
7%
Spinal Cord
16%
Surgery
66%
Survival
10%
Survival Rate
7%
Therapeutic Procedure
43%
Toxicity
13%
Tumor Treating Fields
66%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
17%
Bevacizumab
7%
Chemoradiation Therapy
25%
Chemotherapy
8%
Glioblastoma
100%
Neoplasm
66%
Overall Survival
29%
Progression Free Survival
10%
Recurrent Disease
37%
Study Design
6%
Survival
25%
Survival Rate
7%
Toxicity
13%